Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bouchardy

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2013
How many ovarian cancer patients are eligible for fertility-sparing surgery?D Huber, V Cimorelli, M Usel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smokingN Jourenkova, M Reinikainen, C Bouchardy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifenC Bouchardy, H M Verkooijen, G Fioretta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2016
Right colon cancer: Left behindP Gervaz, M Usel, E Rapiti, et al.
Cancer Research|February 17, 2000
High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancersN Jourenkova-Mironova, K Mitrunen, C Bouchardy, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 29, 1999
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinomaM de Perrot, M Licker, C Bouchardy, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 30, 2013
CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian populationC Bouchardy, H Wikman, S Benhamou, et al.
International Journal of Cancer|August 5, 2000
Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tractC Bouchardy, A Hirvonen, C Coutelle, et al.
Pharmacogenetics|April 26, 2000
Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancersN Jourenkova-Mironova, H Wikman, C Bouchardy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1999
Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer riskN Jourenkova-Mironova, A Voho, C Bouchardy, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 27, 2013
How many ovarian cancer patients are eligible for fertility-sparing surgery?D Huber, V Cimorelli, M Usel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 10, 1998
Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smokingN Jourenkova, M Reinikainen, C Bouchardy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 2002
Increased risk of malignant mullerian tumor of the uterus among women with breast cancer treated by tamoxifenC Bouchardy, H M Verkooijen, G Fioretta, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 15, 2016
Right colon cancer: Left behindP Gervaz, M Usel, E Rapiti, et al.
Cancer Research|February 17, 2000
High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancersN Jourenkova-Mironova, K Mitrunen, C Bouchardy, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 29, 1999
Sex differences in presentation, management, and prognosis of patients with non-small cell lung carcinomaM de Perrot, M Licker, C Bouchardy, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|July 30, 2013
CYP1A1 genetic polymorphisms, tobacco smoking and lung cancer risk in a French Caucasian populationC Bouchardy, H Wikman, S Benhamou, et al.
International Journal of Cancer|August 5, 2000
Role of alcohol dehydrogenase 3 and cytochrome P-4502E1 genotypes in susceptibility to cancers of the upper aerodigestive tractC Bouchardy, A Hirvonen, C Coutelle, et al.
Pharmacogenetics|April 26, 2000
Role of arylamine N-acetyltransferase 1 and 2 (NAT1 and NAT2) genotypes in susceptibility to oral/pharyngeal and laryngeal cancersN Jourenkova-Mironova, H Wikman, C Bouchardy, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 6, 1999
Glutathione S-transferase GSTM3 and GSTP1 genotypes and larynx cancer riskN Jourenkova-Mironova, A Voho, C Bouchardy, et al.
Pageof 9